Filing Details
- Accession Number:
- 0001415889-24-025804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-30 20:59:38
- Reporting Period:
- 2024-10-28
- Accepted Time:
- 2024-10-30 20:59:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1746466 | Equillium Inc. | EQ | Pharmaceutical Preparations (2834) | 821554746 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1797818 | Christine Zedelmayer | 2223 Avenida De La Playa, Suite 105 La Jolla CA 92037 | Sr. Vice President And Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-10-28 | 15,000 | $1.25 | 135,246 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 19, 2024.
- Includes 15,000 shares acquired by the reporting person on June 10, 2024 under the Issuer's 2018 Employee Stock Purchase Plan.